Over 350 Total Lots Up For Auction at Three Locations - MD 02/08, TX 02/10, Ontario 02/14

Fujifilm upgrades ASGE's Institute for Training and Technology with state-of-the-art endoscopic imaging solutions

Press releases may be edited for formatting or style | September 21, 2022 Business Affairs Endoscopy

The system has demonstrated the clinical versatility required for training at ASGE. Data on the system supports applications across a variety of different disease states, most commonly: colorectal polyp detection, EGC detection, H. Pylori assessment, Barretts Esophagus, and GERD detection.

Clinical data shows LCI helps to differentiate mucosal colors by enhancing the contrast of red and white hues, which can improve the detection of early cancers as well as improve the adenoma detection rate. BLI outputs a high intensity ratio of blue-violet light which aids high contrast imaging of microvessels, helping to characterize findings, and to potentially diagnose early gastric cancer accurately.

The technology was debuted at the ASGE Advanced Endoscopy Fellows Program held September 16-17, 2022, led by Amitabh Chak, MD, MASGE and Prabhleen Chahal, MD, FASGE.

“Procedural skills training in GI endoscopy is the foundation of the ASGE’s mission and our programs provide learners the opportunity to gain experience in the latest technologies. Training with Fujifilm’s TRACMOTION device for ESD with their new dual-channel endoscope, for example, will enable healthcare providers to better manage en bloc resections of large, potentially cancerous polyps in the upper and lower GI tract,” said Robert E. Sedlack, MD, MHPE, FASGE, Chair, ASGE Education Council.

About Fujifilm
FUJIFILM Healthcare Americas Corporation is a leading innovator in diagnostic and enterprise imaging solutions designed to meet the evolving needs of healthcare across prevention, diagnosis, and treatment. Fujifilm’s medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy, and endosurgery. The Synapse® Enterprise Imaging portfolio provides healthcare professionals with the imaging and data access needed to deliver a complete patient record. REiLI®, Fujifilm’s artificial intelligence initiative, combines Fujifilm’s rich image-processing heritage with cutting-edge AI innovations to inspire a new tier of clinical confidence. The In-Vitro Diagnostic portfolio provides the golden standard of molecular based immunoassay technology for liver surveillance, cutting edge clinical diagnostic chemicals for leading laboratories across the country and diagnostic chemicals for OEM white labeling products. The company is headquartered in Lexington, Massachusetts. For more information please visit healthcaresolutions-us.fujifilm.com.

You Must Be Logged In To Post A Comment